New award for glatiramer acetate injections

Ended Indefinite Delivery Contract Awarded Last action

Contract number
36E79718D0030
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
Last date to order 100% complete
IDV ceiling
$231,108,670.00
Award type
Single award
Contracting staff
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00012 · Incorporation of drug supply chain security act (dscsa) language $0
Add Subcontract Plan P00011 · Incorporate 2023 sandoz subcontracting plan for glatiramer acetate injection effective 01/01/2023 through 12/31/2023. $0
Exercise an Option P00010 · Exercise option four with sandoz INC for glatiramer acetate INJ with effective period 07/25/2022 through 07/24/2023. $0
Add Subcontract Plan P00009 · Incorporate 2022 sandoz subcontracting plan for glatiramer acetate INJ with effective 01/01/2022 through 12/31/2022. $0
Supplemental Agreement for work within scope P00008 · Price reduction for mometasone nasal spray 40 MG with sandoz, INC. For glatiramer acetate injections contract 36E79718D0030. Effective period is 12/10/2021… $0
Exercise an Option P00007 · Exercise third option year with sandoz, INC. For glatiramer acetate injections contract 36E79718D0030. New period of performance is 07/25/2021 through… $0
Add Subcontract Plan P00006 · Incorporate sandoz 2021 subcontracting plan effective date of 1/01/2021 through 12/31/2021. $0
Exercise an Option P00005 · Exercise 2ND option year for glatiramer national contract with sandoz. New effective date of 7/25/2020 - 7/24/2021. $0
Add Subcontract Plan P00004 · Incorporate 2020 sandoz subcontracting plan. $0
Other Administrative Action P00003 · Price reduction for glatiramer acetate injections with sandoz. New contract prices are effective 11/04/19. $0
Exercise an Option P00002 · Exercise first option year for glatiramer acetate injections with sandoz. New contract period is 07/25/19 - 07/24/20 with no price changes. $0
Add Subcontract Plan P00001 · Incorporate 2019 sandoz subcontracting plan covering 01/01/2019 - 12/31/2019. $0
Original award $0
Show all 13

Quick answers

Who was awarded contract 36E79718D0030?

36E79718D0030 was awarded to Sandoz Inc. by National Acquisition Center (Headquarters) on July 25, 2018.

How much is contract 36E79718D0030 worth?

36E79718D0030's own ceiling is $231,108,670.

Who can order from contract 36E79718D0030?

36E79718D0030 is a single award indefinite delivery contract.

Was contract 36E79718D0030 competed?

The extent of competition for 36E79718D0030 was full and open competition. The government received 2 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV
Try for free Login